ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT.

J Blood Med · 2026 · PMC13242839 · PMID 42261307

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the ATG+PTCy group showed a trend of higher CMV reactivation rate but lower bacterial and fungal infection rates than the ATG group, the differences were not statistically significant ( Table 4 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.